Cardiovascular News Issue 36 – February 2015 US Edition

311

Highlights: -More data needed for routine use of TAVI in lower risk patients -First randomised trial of Absorb indicates device has similar one-year clinical outcomes to Xience -Guillaume Cayla: DAPT duration -Leon Neething: Repairing hearts -Profile: Flavio Ribichini

 

(Visited 16 times, 1 visits today)